Derefter genoptages behandlingen med epoetin alfa med en dosis, som ligger 25% under det tidligere niveau.
Patients should be monitored closely to ensure that the lowest approved dose of Epoetin alfa is used to provide adequate control of anaemia and of the symptoms of anaemia.